New York was the only state to receive the highest mark on the ALS Association’s latest report cards, the association said.
A 22-month survival benefit was seen for a subset of ALS patients whose disease did not progress when treated with NP001 in ...
ALS took many things from columnist Juliet Taylor's late husband, Jeff, including the end of his career, which was ...
Zydus received FDA approval to conduct a Phase 2b trial testing usnoflast, its oral therapy for ALS, in 210 patients.
Columnist Kristin Neva had been searching awhile for equipment that would help with her husband's ALS management. It took repeated searches.
The U.S. Food and Drug Administration (FDA) has lifted the clinical hold on a Phase 1 clinical trial that’s testing AMX0114, Amylyx Pharmaceuticals’ investigational treatment for amyotrophic lateral ...
The ALS Association will host its second ALS Nexus conference in August, with the goal of making the disease a livable one ...
ALS patients' disease progression and improved functional independence and mobility in a real-world setting, per a study.